137 related articles for article (PubMed ID: 7059440)
1. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
[TBL] [Abstract][Full Text] [Related]
3. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
Grainger SL; John VA; Shotton PA; Smith SE
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
[TBL] [Abstract][Full Text] [Related]
4. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.
Kendall MJ; John VA; Quarterman CP; Welling PG
Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709
[TBL] [Abstract][Full Text] [Related]
5. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
Folgering H; van Bussel M
Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
[TBL] [Abstract][Full Text] [Related]
6. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
[TBL] [Abstract][Full Text] [Related]
7. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
Oosterhuis B; Jonkman JH; Kerkhof FA
Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
[TBL] [Abstract][Full Text] [Related]
10. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
[No Abstract] [Full Text] [Related]
11. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
Kendall MJ; Lambert L; Quarterman CP; John VA
J Clin Hosp Pharm; 1981 Dec; 6(4):259-65. PubMed ID: 7338557
[TBL] [Abstract][Full Text] [Related]
12. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
13. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
14. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
[TBL] [Abstract][Full Text] [Related]
15. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
[TBL] [Abstract][Full Text] [Related]
16. A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol.
Nievel JG; Harvard CW
Curr Med Res Opin; 1981; 7(8):503-15. PubMed ID: 7030636
[TBL] [Abstract][Full Text] [Related]
17. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
[TBL] [Abstract][Full Text] [Related]
19. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
20. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
Mucklow JC; Kuhn S
Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
